Project 1: Superfund Chemicals Nutrition and Endothelial Cell Dysfunction

项目1:超级基金化学品营养与内皮细胞功能障碍

基本信息

  • 批准号:
    8249960
  • 负责人:
  • 金额:
    $ 31.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

Atherosclerosis, a chronic inflammatory disease, is still the number one cause of death in the United States. Numerous risk factors for the development of atherosclerosis have been identified, including obesity, hypertriglyceridemia and exposure to Superfund chemicals such as persistent organic pollutants (e.g., RGBs). Plant-based bioactive food components are reported to have antioxidant and anti-inflammatory properties. Our preliminary data suggest that endothelial cell dysfunction and inflammatory events induced by exposure to coplanar PCBs can be markedly down-regulated by bioactive compounds such as flavonoids, events which also can be modified by the cellular lipid milieu. Little is known about mechanisms of nutritional modulation of environmental toxicity. Membrane lipid domains such as caveolae are particularly abundant in endothelial cells, where they are believed to play a major role in the regulation of endothelial vesicular trafficking. More recently, caveolae have also been implicated in the regulation of cell signal transductions. Thus, we hypothesize that caveolae are critical in the cellular responses to Superfund pollutants, lipids, and lipophilic bioactive compounds such as flavonoids. We also hypothesize that the anti-inflammatory properties of flavonoids against chemical insults may be enhanced by omega-3 fatty acids and antagonized or lessened by omega-6 fatty acids. These hypotheses will be tested in vitro as well as in vivo by studying the interactions of PCBs with dietary components such as fatty acids and flavonoids. Importantly, we will use cell and mouse models lacking the caveolin gene to determine the involvement of caveolae in inflammatory outcome. We propose to explore novel mechanisms of nutrient-mediated modulation of Superfund chemical toxicity, and the outcome of our proposed study will lead to novel nutritional recommendations and therapeutic interventions in populations exposed to Superfund chemicals. Superfund chemical exposure, specifically persistent organic pollutants like PCBs, has been linked to a heightened risk of cardiovascular disease to the public. Project 1 intends to investigate the mechanisms used by these chemicals resulting in disease, specifically signaling pathways controlled by the membrane domains, caveolae. Project 1 will focus on means of nutritional intervention by blocking these targets and thus proposing means of protecting the public from the harmful effects of Superfund chemical exposure.
动脉粥样硬化是一种慢性炎症性疾病,仍然是美国的头号死因。 已经确定了许多导致动脉粥样硬化的危险因素,包括肥胖、 高甘油三酯血症和接触超级基金化学品,例如持久性有机污染物(例如, RGB)。据报道,植物性生物活性食品成分具有抗氧化和抗炎作用 特性。我们的初步数据表明,内皮细胞功能障碍和炎症事件诱发 暴露于共面 PCB 可以被生物活性化合物(例如类黄酮)显着下调, 也可以通过细胞脂质环境改变的事件。对于营养的机制知之甚少 调节环境毒性。膜脂质结构域(例如小凹)在 内皮细胞,据信它们在内皮囊泡的调节中发挥重要作用 贩运。最近,小凹也与细胞信号转导的调节有关。 因此,我们假设小凹在细胞对超级基金污染物、脂质和脂质的反应中至关重要。 亲脂性生物活性化合物,例如类黄酮。我们还假设抗炎药 omega-3 脂肪酸可能会增强黄酮类化合物抵抗化学损伤的特性并拮抗 或因 omega-6 脂肪酸而减少。这些假设将通过研究在体外和体内进行测试 PCB 与脂肪酸和类黄酮等膳食成分的相互作用。重要的是,我们将 使用缺乏小窝蛋白基因的细胞和小鼠模型来确定小窝蛋白参与 炎症结果。我们建议探索营养介导的调节的新机制 超级基金化学毒性,我们提出的研究结果将带来新的营养 针对接触超级基金化学品人群的建议和治疗干预措施。超级基金 化学品暴露,特别是持久性有机污染物,如多氯联苯,与较高的风险有关 向公众介绍心血管疾病。项目 1 旨在研究这些所使用的机制 导致疾病的化学物质,特别是由膜域控制的信号通路, 小穴。项目1将重点关注营养干预手段,通过阻止这些目标,从而 提出保护公众免受超级基金化学品接触有害影响的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BERNHARD HENNIG其他文献

BERNHARD HENNIG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BERNHARD HENNIG', 18)}}的其他基金

Project 1: Superfund Chemicals Nutrition and Endothelial Cell Dysfunction
项目1:超级基金化学品营养与内皮细胞功能障碍
  • 批准号:
    8053921
  • 财政年份:
    2010
  • 资助金额:
    $ 31.74万
  • 项目类别:
Nutrition and Superfund Chemical Toxicity
营养和超级基金化学毒性
  • 批准号:
    7916293
  • 财政年份:
    2009
  • 资助金额:
    $ 31.74万
  • 项目类别:
Nutrition and Superfund Chemical Toxicity
营养和超级基金化学毒性
  • 批准号:
    7897031
  • 财政年份:
    2009
  • 资助金额:
    $ 31.74万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    7417304
  • 财政年份:
    2008
  • 资助金额:
    $ 31.74万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    6932257
  • 财政年份:
    2005
  • 资助金额:
    $ 31.74万
  • 项目类别:
Superfund Chemicals Nutrition and Endothelial Cell Dysfu
超级基金化学品营养与内皮细胞失调
  • 批准号:
    6932244
  • 财政年份:
    2005
  • 资助金额:
    $ 31.74万
  • 项目类别:
SUPERFUND CHEMICALS, NUTRITION, ENDOTHELIAL CELL DYSFUNCTION
SUPERFUND 化学品、营养、内皮细胞功能障碍
  • 批准号:
    6630568
  • 财政年份:
    2002
  • 资助金额:
    $ 31.74万
  • 项目类别:
SUPERFUND CHEMICALS, NUTRITION, ENDOTHELIAL CELL DYSFUNCTION
SUPERFUND 化学品、营养、内皮细胞功能障碍
  • 批准号:
    6457648
  • 财政年份:
    2001
  • 资助金额:
    $ 31.74万
  • 项目类别:
SUPERFUND CHEMICALS, NUTRITION, ENDOTHELIAL CELL DYSFUNCTION
SUPERFUND 化学品、营养、内皮细胞功能障碍
  • 批准号:
    6301507
  • 财政年份:
    2000
  • 资助金额:
    $ 31.74万
  • 项目类别:
SUPERFUND CHEMICALS AND ENDOTHELIAL CELL DYSFUNCTION
SUPERFUND 化学品和内皮细胞功能障碍
  • 批准号:
    6217743
  • 财政年份:
    1999
  • 资助金额:
    $ 31.74万
  • 项目类别:

相似国自然基金

“消炎良境”铂药纳米制剂增强免疫治疗转移性结直肠癌的研究
  • 批准号:
    82073398
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
面向水中非甾体类消炎药选择性吸附光催化分解的金属有机框架的设计与机理研究
  • 批准号:
    21906007
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
  • 批准号:
    10603408
  • 财政年份:
    2023
  • 资助金额:
    $ 31.74万
  • 项目类别:
Regulation of plasma LDL and HDL by microRNA-541-3p
microRNA-541-3p 对血浆 LDL 和 HDL 的调节
  • 批准号:
    10733641
  • 财政年份:
    2023
  • 资助金额:
    $ 31.74万
  • 项目类别:
Endothelial Metabolic Reprogramming by Interferon-gamma in Coronary Artery Disease
干扰素γ在冠状动脉疾病中的内皮代谢重编程
  • 批准号:
    10662850
  • 财政年份:
    2023
  • 资助金额:
    $ 31.74万
  • 项目类别:
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
南亚人的脂蛋白代谢和过度心脏代谢风险
  • 批准号:
    10705254
  • 财政年份:
    2022
  • 资助金额:
    $ 31.74万
  • 项目类别:
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
南亚人的脂蛋白代谢和过度心脏代谢风险
  • 批准号:
    10539768
  • 财政年份:
    2022
  • 资助金额:
    $ 31.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了